4.6 Article

Synchronization of the cell cycle using lovastatin

Journal

CELL CYCLE
Volume 7, Issue 15, Pages 2434-2440

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/cc.6364

Keywords

synchronization; lovastatin; G(1) arrest; mevalonate; cyclins

Categories

Funding

  1. U. S. Army Medical Research Acquisition Activity [W81XWH-06-1-0339]
  2. National Cancer Institute [R01 CA87548]
  3. National Institutes of Health [p30-CA16672]

Ask authors/readers for more resources

Synchronization by Lovastatin arrests many cell types reversibly in the G(1) phase of the cell cycle. Here we show that Lovastatin (10 mu M) mediates cell cycle arrest in human breast cancer cells, MCF-7 and MDA-MB-231, where 85% of cells accumulate in the G(1) phase of the cell cycle. Addition of mevalonate (at 100X the Lovastatin concentration) releases the cells from the G(1) arrest and allows for synchronous entry into late G(1), S and G(2)/M phases of the cell cycle. The expressions of different cyclins as a marker for different phases of the cell cycle are detected by western blot analysis and indicative of synchronous transition into each of cell cycle phases following the initial G(1) arrest. Due to its level of synchrony and high yield of synchronous populations of cells, Lovastatin method of cell synchronization can be used for examining gene expression patterns in a variety of different cell lines.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available